Objective: The objective of this review was to update evidence‐based medicine
recommendations for treating motor symptoms of Parkinson's disease (PD). Background …

Sleep disorders are among the most common non-motor manifestations in Parkinson's
disease (PD) and have a significant negative impact on quality of life. While sleep disorders …

Parkinson’s Disease and Its Management - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …

Abstract The Movement Disorder Society (MDS) Task Force on Evidence‐Based Medicine
(EBM) Review of Treatments for Parkinson's Disease (PD) was first published in 2002 and …

The objective was to update previous evidence‐based medicine reviews of treatments for
motor symptoms of Parkinson's disease published between 2002 and 2005. Level I …

Objective To summarize the 2010 EFNS/MDS‐ES evidence‐based treatment
recommendations for the management of P arkinson's disease (PD). This summary includes …

Non-motor symptoms (NMS) of Parkinson's disease remain the most under-appreciated and
under-researched when taken as a whole. Data is emerging that it is the “totaL” burden of …

Non-motor symptoms are a key component of Parkinson's disease, possibly representing a
clinical biomarker of its premotor phase. The burden of non-motor symptoms can define a …

Dopamine agonists (DA) are therapeutic agents that are commonly used in the treatment of
Parkinson's disease (PD). They can reduce undesired motor fluctuations and delay the …

Background Insomnia is a frequent complaint of patients with Parkinson's disease, and it
negatively affects quality of life. Drugs that improve both sleep and parkinsonism would be of …